Delivery Order SPE2DB22D1103-SPE2DB24FTGA9
Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR. The $2,458.62 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The potential value of this order is $1,171.68, with a completion date of February 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 24,000 unit capsules of Creon DR 100s, valued at $3,406.32 with a firm fixed price structure. The contract, awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, represents a non-set-aside, competitively awarded transaction. This delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 36,000 units of CREON DR 100s capsules. The $6,032.32 contract has a completion date of February 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a $98,647.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 units of the pharmaceutical product CREON DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is not subject to any set-aside designation. Amerisourcebergen Drug...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of the pharmaceutical product CREON DR 100S capsules. The order has a potential value of $4,459.11 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and is not operating under a set-aside designation. This delivery order is part of a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,111.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 12,000 units of the pharmaceutical product CREON DR 100S Capsules. The contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. Amerisourcebergen Drug Corp also holds...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product Creon DR. The award, valued at $7,323.00, has a period of performance through March 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR 100S. The $1,128.10 delivery order has a completion date of January 3, 2024 and was awarded on January 2, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has an established history of providing pharmaceutical products and medical supplies to support Department...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of CREON DR 100S capsules. The $1,357.76 contract has a completion date of February 1, 2024 and does not contain a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, providing pharmaceutical products and medical supplies to support military treatment programs and...